Loading
No description yet: the sentence for this tag has not been written. 17 records carry it: 16 protocols, 1 technology.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Baseline tests and monitoring before and during checkpoint inhibitor treatment Before immunotherapy such as pembrolizumab or nivolumab starts, your team checks your blood count, a panel of blood chemistry and your thyroid. European guidance adds cortisol, blood sugar, a heart tracing and heart blood tests. They ask about autoimmune conditions and transplants. Liver and thyroid tests are repeated during treatment, because these side effects often cause no symptoms. | none | none | protocol | ||
Blood side effects of checkpoint inhibitors: low platelets, haemolysis, neutropenia and marrow failure Uncommonly, checkpoint inhibitor immunotherapy causes immune-related blood problems: low platelets (bruising or bleeding), breakdown of red cells (yellow skin or eyes, dark urine, a high temperature) or low white cells (infection risk). Blood tests find them. Treatment typically includes steroids, and a blood specialist may be involved. Report unexplained bruising or bleeding straight away. | none | none | protocol, haematology | ||
Checkpoint inhibitor hypophysitis and adrenal insufficiency: emergency treatment, replacement and steroid emergency card Immunotherapy can damage the pituitary or adrenal glands so the body stops making cortisol, a hormone needed to survive illness. Anyone on immunotherapy who becomes very unwell should be treated for low cortisol at once while tests are done. Most then need hydrocortisone tablets long term, a steroid emergency card, and to know the sick day rules. Immunotherapy can usually carry on. | none | none | protocol, acute-oncology, endocrine | ||
Eye side effects of checkpoint inhibitors: dry eye, uveitis and optic neuritis Immunotherapy can cause dry, gritty eyes or inflammation inside the eye (uveitis); inflammation of the nerve to the eye has also been reported. Contact your hospital's 24-hour number straight away about dry, itchy, painful or swollen eyes, sensitivity to light or any change in eyesight. Dry eye and uveitis at the front of the eye are usually treated with drops, and immunotherapy usually continues. | none | none | protocol, ophthalmology | ||
Immune endocrine damage is usually permanent, and almost nobody is told Most immune side effects of checkpoint inhibitors settle. The hormone glands are the exception: a pituitary, thyroid, adrenal or insulin-making gland destroyed by the immune system does not grow back, and the replacement treatment that follows is usually for life. In the follow-up cohorts 83 per cent of hormone problems were still present three months after the drug stopped. | Melanoma, Non-small-cell lung cancer, Renal cell carcinoma | none | rejuvenation, survivorship, late-effects | ||
Immune-mediated hepatitis from checkpoint inhibitors, by grade Immunotherapy can inflame the liver, often without symptoms, so liver tests are checked before each dose. A mild rise is watched. A larger rise means pausing treatment and usually steroids; a severe one can mean stopping it for good. Contact the hospital straight away for yellow skin or eyes, feeling very sleepy, dark urine, unexplained bleeding or bruising, or pain in the right side of the tummy. | none | none | protocol, acute-oncology | ||
Immune-related diarrhoea and colitis from checkpoint inhibitors, by grade Immunotherapy drugs such as pembrolizumab, nivolumab and ipilimumab can inflame the bowel, causing diarrhoea, tummy pain or blood in the stool. Tell your cancer team if you get diarrhoea. Mild cases are watched; anything more is treated with steroids, and if steroids have not worked within 3 to 5 days, with a drip such as infliximab. | none | none | protocol, acute-oncology | ||
Immune-related myocarditis from checkpoint inhibitors Rarely, immunotherapy inflames the heart muscle. It most often starts in the first three months and can be fatal, so new chest pain, breathlessness, palpitations, fainting, or new muscle weakness, drooping eyelids or double vision need urgent assessment. It is treated in hospital with high-dose steroids, started as early as possible. | none | none | protocol, acute-oncology, cardio-oncology | ||
Immune-related pneumonitis from checkpoint inhibitors, by grade Immunotherapy can inflame the lungs, during treatment or after it has ended. Tell your cancer team about a new cough, breathlessness, chest pain or fever. A detailed CT scan of the chest is the main test, and steroids are the main treatment, given through a drip in severe cases. Treatment is usually paused, and may be stopped for good after the most severe cases. | none | none | protocol, acute-oncology | ||
Immune-related skin reactions from checkpoint inhibitors, including blistering and severe erosive rashes Rash and itching are among the commonest and earliest side effects of immunotherapy and are usually mild. Tell your cancer team about any skin change. Ring the hospital's 24-hour number straight away for a rash that is spreading, or for swollen, blistering or peeling skin. Skin pain and sores in the mouth, eyes or genitals are also signs doctors treat as serious. | none | none | protocol, dermatology | ||
Immune-related type 1 diabetes and diabetic ketoacidosis from checkpoint inhibitors Rarely, immunotherapy destroys the cells that make insulin. Blood sugar can rise quickly and become dangerous (diabetic ketoacidosis). Thirst, passing a lot of urine, being sick or feeling drowsy need urgent help. It is treated with insulin, which is almost always lifelong, and not with steroids. | none | none | protocol, endocrine, acute-oncology | ||
Joint, muscle and other rheumatic side effects of checkpoint inhibitors Immunotherapy can cause joint pain and swelling, stiffness in the shoulders and hips, a dry mouth and eyes or, rarely, muscle inflammation. Some people need only painkillers or anti-inflammatories; others need steroids and a rheumatologist. Ring your hospital's 24-hour number about new aches, stiff or swollen joints or weak muscles, and straight away if you are breathless or have palpitations. | none | none | protocol, rheumatology | ||
Kidney inflammation (immune-related nephritis) from checkpoint inhibitors Immunotherapy can sometimes inflame the kidneys. It is usually found when the creatinine on a blood test rises. Other causes are looked for, some medicines may be stopped, immunotherapy is paused, and steroids are the first treatment if the immunotherapy is the cause. Restarting immunotherapy later may be considered. | none | none | protocol, nephrology | ||
Neurological side effects of checkpoint inhibitors: myasthenia gravis, Guillain-Barré syndrome, meningitis and encephalitis Immunotherapy can inflame the nerves, the brain or the junction between nerve and muscle. Serious cases are uncommon. Drooping eyelids, double vision, trouble swallowing or speaking, weakness spreading up the legs, numbness, a headache with a stiff neck, confusion or a seizure need urgent assessment. Treatment is steroids, often with immunoglobulin or plasma exchange, and a neurologist. | none | none | protocol, acute-oncology, neurology | ||
Restarting a checkpoint inhibitor after an immune-related side effect After an immunotherapy side effect has settled, your team may offer to restart treatment. In one large database study, about 3 in 10 restarts were followed by the same side effect again. After Guillain-Barré syndrome or severe myasthenia gravis, guidelines say to stop for good, and after heart inflammation to seriously consider it. The decision weighs the cancer benefit against the risk. | none | none | protocol | ||
Steroid taper after immunotherapy side effects, with Pneumocystis prophylaxis and adrenal checks Steroids for an immunotherapy side effect are reduced gradually, in general over at least 4 to 6 weeks, and the side effect can return as the dose comes down. A month or more at 20 mg of prednisone a day or above raises the risk of Pneumocystis pneumonia, so a preventive antibiotic (usually co-trimoxazole) may be offered. Your own steroid production may need checking before the last tablets stop. | none | none | protocol, infection-prevention | ||
Thyroid inflammation and underactive thyroid from checkpoint inhibitors Immunotherapy can inflame the thyroid gland. It may briefly make the thyroid overactive (palpitations, shakiness, feeling hot) and then underactive (tiredness, feeling cold), and symptoms can be mild or absent. The underactive phase is often permanent. It is found on routine blood tests, generally treated with tablets rather than steroids, and immunotherapy usually carries on. | none | none | protocol, endocrine |